Navigation Links
RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014
Date:7/31/2014

June 30, 2014 the company repurchased 4.4 million shares at a cost of $208.1 million.

Dividend program
The ResMed board of directors has today declared a quarterly dividend of $0.28 per share, which represents a 12 percent increase from the previous quarterly dividend of $0.25.  The dividend will have a record date of Aug. 21, 2014, and be payable on Sept. 18, 2014. The dividend will be paid in U.S. currency to holders of ResMed's common stock trading on the New York Stock Exchange. Holders of Chess Depositary Instruments trading on the Australian Securities Exchange will receive an equivalent amount in Australian currency, based on the exchange rate on the record date, and reflecting the 10:1 ratio between CDIs and NYSE shares.  The ex-dividend date will be Aug. 19, 2014 for common stock holders and for CDI holders.  ResMed has received a waiver from the ASX's settlement operating rules, which will allow ResMed to defer processing conversions between its common stock and CDI registers from Aug. 19, 2014 through Aug. 21, 2014, inclusive.

Webcast details
ResMed will discuss its financial and business results as well as its business outlook on its webcast at 1:30 p.m. U.S. Pacific Daylight Time today. The live webcast of the call can be accessed on ResMed's website at www.resmed.com. Please note that the format of the call has not changed. Please allow extra time prior to the call to visit the website and download the streaming media player (Windows Media Player), required to listen to the internet broadcast. The online archive of the broadcast will be available after the live call on ResMed's website. In addition, a telephone replay of the conference call will be available approximately 90 minutes after the call by dialing 630-652-3042 (domestic) and +1 630-652-3042 (international) and entering a passcode of 37658760.  The telephone replay will be available from July 31, 2014
'/>"/>

SOURCE ResMed Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. ResMed riceve uningiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa
2. ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe
3. ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents
4. ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results
5. ResMeds New Nasal Pillows System is Our Quietest Yet; Ultra-light AirFit P10 Packs Powerful Performance in Just over 1.5 Ounces
6. ResMed Announces Conference Call And Webcast To Discuss Second Quarter 2014 Results
7. BMC to protect its rights in patent fight with ResMed
8. Apex reagiert energisch auf ResMed Patentklage
9. ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
10. ResMed Inc. Announces Record Financial Results For The Quarter Ended September 30, 2013
11. ResMeds New Nasal Mask Sets the Bar for Comfort and Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015 Quietly, sedately, Morocco,s ... the domestic pharmaceutical industry is strong, with a well-developed ... high international standards. One place where the ... sub-Saharan Africa: Morocco has quietly become the second largest ... Africa . Indeed, Moroccan pharma companies have been ...
(Date:7/31/2015)... , July 31, 2015 ... Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray ... Hydrostatic Weighing) - Global Analysis & Forecast to 2019", ... was pegged at $911.1 Million 2014 and is estimated ... a CAGR of 9.4% from 2014 to 2019. ...
(Date:7/30/2015)... , July 30, 2015 IRIDEX Corporation ... release its second quarter 2015 financial results after the ... In conjunction with the release, the Company will host ... 5:00 p.m. Eastern Time on Thursday, August ... quarter and other business developments. Interested parties ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... May 25, 2012  ... and Multilab Indústria e Comércio de Produtos Farmacêuticos ... jointly announced that both parties have signed an ... Brazil, "Takeda Brazil"), a wholly-owned subsidiary of Takeda, ...
... 2012  The National Organization for Rare Disorders (NORD) applauds legislation ... the Food and Drug Administration Safety & Innovation Act ... the most comprehensive improvements to public policy for rare disease ... . (Logo: http://photos.prnewswire.com/prnh/20110719/DC37656LOGO-b ) ...
Cached Medicine Technology:Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 2Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 3Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil 4NORD Calls Senate Bill Most Important Since Orphan Drug Act 2
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s only Thermage ... also the first provider of Exilis non-surgical fat reduction in New York. Due ... attracted a large International clientele. Many patients travel to New York to get ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight On ... on October 3, 2015. The Ride to Fight On is a cycling fundraiser that ... Healthcare, The West Clinic and The University of Tennessee Health Science Center. A health ...
(Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
(Date:7/31/2015)... ... July 31, 2015 , ... M3 USA MDLinx.com, source of the ... new Board Exam Courses. , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round ... MDLinx makes preparing for the exam easy and painless. MDLinx offers thousands of ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to an ... gathered to see if they could reach a consensus on the steps that need ... facelifts. Overall, the group reached 90 percent consensus on a series of steps that ...
Breaking Medicine News(10 mins):Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... ... teach participants unique personal marketing strategies to find employment with a six-point system “The ... is a former talk show host in Columbia at WVOC 560 AM; Kenneth Shuler ... be held for Thomas providing free career counseling services , ...
... ... infection 33 times greater than that reported for our accredited ambulatory surgery centers. ... (PRWEB) June 18, ... Schaefer, Michael Jhung et al (JAMA 2010;303(22):2273 - 2279) correctly places emphasis on the ...
... disorder affecting one in 100 people worldwide. Most cases aren,t ... hallucinations as a teenager or adult. By that time, the ... difficult to treat. In a paper published recently online ... the University of North Carolina at Chapel Hill and Columbia ...
... The National Heart, Lung, and Blood Institute (NHLBI), part of ... to determine if the safety and efficacy of red blood ... been stored. One of the grants supports the first large, ... patients who receive transfusions of red blood cells that have ...
... ... to help women restore energy, passion and healthy hormonal balance. , ... Tampa, FL (Vocus) June 21, 2010 ... supplement for women. Dan-e™ is made of a patent-pending blend of Pro-Hormones and vital ...
... University of Leicester and the University of Ferrara in Italy ... to relieve cancer pain without causing many of the side ... show that 90% of cancer patients experience pain in the ... problem. Currently, the use of drugs like morphine produces side ...
Cached Medicine News:Health News:Columbia Extreme Job Makeover Slated for June 26 2Health News:Columbia Extreme Job Makeover Slated for June 26 3Health News:Infection Rate in Accredited Ambulatory Facilities is Lower than in Hospitals 2Health News:Brain signs of schizophrenia found in babies 2Health News:NHLBI funds research to improve safety of red blood cell transfusions 2Health News:NHLBI funds research to improve safety of red blood cell transfusions 3Health News:NHLBI funds research to improve safety of red blood cell transfusions 4Health News:NHLBI funds research to improve safety of red blood cell transfusions 5Health News:NHLBI funds research to improve safety of red blood cell transfusions 6Health News:NHLBI funds research to improve safety of red blood cell transfusions 7Health News:World Renowned Physician Launches Dan-e™ All-Natural Nutritional Supplement for Women 2Health News:New drugs to relieve cancer pain 2
... D15/810 diode laser is a versatile and ... soft tissue applications. With excellent hemostatic and ... flexible fiber optic delivery system that allows ... environments alike.,Compact and portable, the Ceralas D15/810 ...
... II is a monoclonal antibody based ... identification of Neisseria gonorrhoeae. The test ... run with no heating or pretreatment. ... viable or fresh cultures. GonoGen&trade II ...
The One-Step Gonorrhea Antigen Tests are qualitative immunoassays for detecting the Gonorrhea Antigen (NGH) in secretory products (swab)....
... thermal keratoplasty (LTK). This procedure was FDA ... reduction of hyperopia from +0.75 to +2.50 diopters ... to 0.75 diopters of astigmatism and refractive stability ... refractive surgery, LTK is not performed in an ...
Medicine Products: